Sponsor Pipeline

GeneQuantum Healthcare (Suzhou) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
1
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07673029 A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or… HER2-positive Breast Cancer Recruiting
Phase 1/2
NCT06464055 A Study of GQ1010 in Subjects With Advanced Solid Tumors Advanced Malignant Solid Tumors Recruiting
Disease Areas
Breast Cancer (1) HER2-Positive Breast Cancer (1)
Get alerts when GeneQuantum Healthcare (Suzhou) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free